2015-2019 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape

August 2015 | 436 pages | ID: 247F0D79ED4EN
Venture Planning Group

Abstracts

Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400.

2015-2019 New Frontiers in theU.S. Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is VPGMarketResearch's new analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in theU.S. automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expand ing microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Supplier Shares, Sales and Volume Forecasts

• Sales and market shares of major suppliers of microbiology products, by individual test.
• Five-year test volume and sales forecasts for over 100 microbiology assays.
• Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

U.S.Market Overview

• Review of the market dynamics, trends, structure, size, growth and major suppliers.
• Estimated universe of laboratories performing microbiology testing.
• Specimen, test volume and sales forecasts.

Business Opportunities and Strategic Recommendations

• Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Specimen Types

• Urine
• Sterile Fluids: Blood, Serum, CSF
• Throat Swabs, Respiratory Secretions
• Genital Secretions
• Stool
• Abscess/Wound
• Sputum
• Saliva

Applications

• Microbial Identification
• Antibiotic Susceptibility
• Urine Screening
• Blood Cultures

Review of Major Automated Systems

• Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
• The report features analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Cand ida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia and others.

Technology Assessment

• Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
• Global listings of companies developing or marketing microbiology products by individual test.

Competitive Strategies

• Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:

• Abbott
• Affymetrix
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biokit
• bioMerieux
• Bio-Rad
• Biotest
• Cepheid
• CellMark Forensics/LabCorp
• Decode Genetics
• Diadexus
• Diamedix
• DiaSorin
• Eiken Chemical
• Elitech Group
• Enzo Biochem
• Exact Sciences
• Fujirebio
• Grifols
• Hologic/Gen-Probe
• Illumina
• ID Biomedical/GSK
• Kreatech/Leica
• Li-Cor Biosciences
• Lonza
• Monogram Biosciences
• Myriad Genetics
• Ortho-Clinical Diagnostics
• Perkin Elmer/Caliper
• Proteome Sciences
• Qiagen
• Roche
• Scienion
• Sequenom
• SeraCare
• Siemens
• Sierra Molecular
• Shimadzu
• Takara Bio
• Tecan
• Thermo Fisher
• Wallac/PE
• Wako

Contains 436 pages and 94 tables

Contents

I. Introduction

II. Worldwide Market an
d Technology Overview
A. Introduction
  1. Major Factors Affecting Market Penetration of Microbiology Instrumentation
  2. Traditional Practices
  3. Technological Challenges
  4. Automation: Impact on the Microbiology Laboratory and the Patient
B. Major Specimen Types
  1. Urine
  2. Sterile Fluids: Blood, Serum, and CSF
  3. Throat Swabs and Respiratory Secretions
  4. Genital Secretions
  5. Stool
  6. Abscess/Wound
  7. Sputum
  8. Saliva
C. Test Applications
  1. Microbial Identification
  2. Antibiotic Susceptibility
  3. Urine Screening
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. Blood Cultures
D. Major Microbiology Automated and Semiautomated Systems
  1. Multiple Purpose Microbiology Systems
  2. Specialized Microbiology Systems
  3. Molecular Diagnostic Systems
  4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
  1. Molecular Diagnostics (Amplification Methods, Sequencing, Microarrays/Biochips)
    a. DNA Sequencing
      Introduction
      Sequencing Methods
      Autoradiography
      The Human Genome Project
      Sequencing Automation
      Image Scanners
      Fluorescent Detection
      Gene Profiling
      Gene Expression
      Polymorphism Screening
      Protein Interaction Networks
    b. DNA And RNA Probe Technology
      Basic Principles
      Probe Preparation
      The DNA Probe Test
        Sample Preparation
        Hybridization
        Separation
        Detection/Measurement
      Test Formats
        Filter Hybridization
        Southern Blot
        Northern Blot
        In Situ Hybridization
        Others
      Labeling Techniques
      Amplification Methods
        Polymerase Chain Reaction
        Temperature Cyclers
        PCR Variations
          Immuno-PCR
          QC-PCR
          DAP-PCR
        Strand Displacement Activation
        TMA
        Ligase Chain Reaction
        Branched DNA
        Hybridization Protection Assay
        Nucleic-Acid Sequence-Based Amplification
        Self-Sustained Sequence Replicase
        Others
          Ampliprobe
          CAR
          CAS
          CPT
          Dendritic Polymer Technology
          ISO-CR
          LAT
          Probe
          RAMP
          Repair Chain Reaction
          Rolling Circles
          Sequence Independent Gene Amplification
          Sequence Initiation Reaction
          SISPA
          Solid Phase Amplification
    c. Detection Technologies
      Radioactive Methods
        Overview
        Major Isotopes
          P-32
          S-35
          H-3
          I-125
      Non-Isotopic Methods
        Enzymatic Labels
        Chemical Labeling
          Indirect Chemical Labeling
          Direct Chemical Labeling
        Fluorescence
        Chemiluminescence
        Electrical Conductivity
    d. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
      Liquid Transportation and Mixing
      Separation
      Reaction
      Detection
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other

III. U.S.

A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares

IV. Major Product Development Opportunities

V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

VII. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. Competitive Assessments

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Caliper
Cepheid
Decode
Diadexus
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Hologic/Gen-Probe
Illumina
ID Biomedical/GSK
Kreatech
Li-Cor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
Nanogen/Elitech
Novartis Diagnostics/Grifols
Orchid CellMark
Ortho-Clinical Diagnostics
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher/Life Technologies
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Laboratories Performing Microbiology Tests by Market Segment
U.S.A. Hospital Laboratories Performing Microbiology Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
U.S.A. All Market Segments Microbiology Specimen Volume
U.S.A. Hospital Laboratories Microbiology Specimen Volume
U.S.A. Physician Offices/Group Practices Microbiology Specimen Volume
U.S.A. Public Health Laboratories Microbiology Specimen Volume
U.S.A. Commercial/Private Laboratories Microbiology Specimen Volume
U.S.A. Microbiology Test Volume by Market Segment
U.S.A. Microbiology Test Volume by Application
U.S.A. Microbial Identification Test Volume by Market Segment
U.S.A. Urine Screening Test Volume by Market Segment
U.S.A. Blood Culture Test Volume by Market Segment
U.S.A. Antibiotic Susceptibility Test Volume by Market Segment
U.S.A. Microbiology Consumables Market by Application
U.S.A. Microbiology Consumables Market by Market Segment
U.S.A. Microbial Identification Consumables Sales by Market Segment
U.S.A. Antibiotic Susceptibility Consumables Sales by Market Segment
U.S.A. Blood Culture Consumables Sales by Market Segment
U.S.A. Urine Screening Consumables Sales by Market Segment
U.S.A. All Market Segments Infectious Disease Test Volume Forecast by Assay
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast by Test
U.S.A. Infectious Disease Blood Screening NAT Volume Forecast by Assay
U.S.A. Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
U.S.A. HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Molecular Diagnostics Market Sales and Shares of Major Suppliers